MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

BRCA research information

From Medicineworld.org: BRCA research information

Breast cancer treatment Breast cancer main Breast cancer news  

  • Two The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer

  • Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer

  • Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2

  • A new scoring system for the chances of identifying a BRCA1/2 mutation

  • Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene

  • BRCA1 and BRCA2 Germline Mutations in Lymphoma Patients

  • Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations

  • Cancer Incidence in BRCA1 Mutation Carriers

  • Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

  • BRCA2 Gene Mutations in Families With Aggregations of Breast and Stomach Cancers

  • The genetic attributable risk of breast and ovarian cancer

  • The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews

  • Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer

  • BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer

  • BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

  • Impact of Germline Brca1 Mutations and Overexpression of P53 on Prognosis and Response to Treatment Following Breast Carcinoma: 10-Year Follow-Up Data

  • Improved Survival in Women with BRCA-Associated Ovarian Carcinoma

  • BRCA1 Functions as a Differential Modulator of Chemotherapy-Induced Apoptosis

  • Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

  • Outcome of Conservatively Managed Early-Onset Breast Cancer by Brca1/2 Status

  • Survival In Prospectively Ascertained Familial Breast Cancer: Analysis of a Series Stratified By Tumour Characteristics, Brca Mutations and Oophorectomy

  • A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube

  • Risk of Endometrial Carcinoma Associated with BRCA Mutation

  • Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

  • A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

  • Cancer Risks in BRCA2 Mutation Carriers

  • Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers

  • Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

  • Breast Cancer Risk Assessment Models: Applicability to African-American women

  • Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

  • Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

  • The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

  • Modification of BRCA1- and BRCA2: Associated Breast Cancer Risk by AIB1 Genotypeand Reproductive History

  • On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance

  • The Effectiveness of the Gail Model in Estimating Risk for Development of Breast Cancer in women under 40 years of age

  • Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling

  • Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic

  • BRCA2 Mutation Carriers, Reproductive Factors and Breast Cancer Risk

  • Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  • Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

  • Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population-based study

  • Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study

  • Reproductive Factors and Ovarian Cancer Risk in Jewish BRCA1 And BRCA2 Mutation Carriers (United States)

  • Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

  • Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

  • Tamoxifen and Risk of Contralateral Breast Cancer in BRCA1 And BRCA2 Mutation Carriers: A Case-Control Study

  • Smoking and the risk of breast cancer among carriers of BRCA mutations

  • Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

  • TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies

  • Life Insurance and Breast Cancer risk Assessment: Adverse Selection, Genetic Testing Decisions, and Discrimination

  • Preempting Genetic Discrimination and Assaults on Privacy: Report of a Symposium

  • Low-Penetrance Susceptibility to Breast Cancer Due to CHEK2*1100delC in Noncarriers of BRCA1 or BRCA2 Mutations

  • A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer

  • Frequency of CHEK2*1100delC in New York Breast Cancer Cases and Controls

  • Psychosocial Predictors of BRCA Counseling and Testing Decisions among Urban African-American Women

  • What Do Ratings of Cancer-Specific Distress Mean Among Women at High Risk of Breast and Ovarian Cancer?

  • Breast cancer genetics in African Americans

  • Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2

  • Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

  • Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With Mutations: A Decision Analysis

  • Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers

  • Effect of Prevention Strategies on Survival and Quality-Adjusted Survival of Women With BRCA1/2 Mutations: An Updated Decision Analysis

  • Genetic testing for a BRCA1 mutation: Prophylactic Surgery and Screening behavior in women 2 years post testing

  • Reoperations after prophylactic mastectomy with or without implant reconstruction

  • Effectiveness of Modena Surveillance Program for Women at Risk For Breast Cancer

  • Using Sonography to Screen Women with Mammographically Dense Breasts

  • MRI of Occult Breast Carcinoma in a High-Risk Population

  • American Cancer Society Guidelines for Breast Cancer Screening: Update 2003

  • Cancer Genetics Network Ovarian Screening Study: Physician Practice Patterns in Screening Women at High Risk for Ovarian Cancer

  • A Gonadotropin-Releasing Hormone Agonist (Gnrha)-Based Chemoprevention Regimen That Reduces Mammographic Density in Brca Carriers While Maintaining Good Quality of Life (Qol), Bone Density, and Reproductive Options

  • Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

  • Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation

  • Effect of Fenretinide on Ovarian Carcinoma Occurrence

  • Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

  • Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

  • Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation

  • Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 Mutations

  • Tubal Ligation and Risk of Ovarian Cancer in Carriers of Brca1 or BRCA2 Mutations: A Case-Control Study

  • Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers


  • Did you know? Until recently breast cancer topped the list of leading causes of cancer deaths in women, but lately lung cancer has claimed the top position.

    Medicineworld.org: BRCA research information

    BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer symptoms| Treatment by stage| Surgical treatment| Chemotherapy| Chemo drugs| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy| Radiation therapy| Monoclonal therapy| High dose chemotherapy| Recurrent breast cancer| Bisphosphonates| Pregnancy and breast cancer| Risk factors| Risk details| My risk| Comprehensive| Breast cancer statistics| African Americans| Ashkenazi| Asians| Hispanic| Men| Native Americans| Older women| Younger women| Pregnant women| BRCA|

    Copyright statement
    The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.